Abbott India

44
Sell
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE358A01014
  • NSEID: ABBOTINDIA
  • BSEID: 500488
INR
27,610.00
-75 (-0.27%)
BSENSE

Jan 28

BSE+NSE Vol: 3.64 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 9.58% vs 9.35% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 16.62% vs 20.53% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -8.19% vs -22.14% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 17.75% vs 26.52% in Mar 2024

Compare Profit and Loss Results of Abbott India
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
6,409.00
2,242.00
4,167.00
185.86%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
6,409.00
2,242.00
4,167.00
185.86%
Expenditure (Ex Depriciation)
Stock Adjustments
-180.00
-54.00
-126.00
-233.33%
Raw Materials Consumed
3,677.00
1,085.00
2,592.00
238.89%
Power & Fuel Cost
15.00
192.00
-177.00
-92.19%
Employee Cost
587.00
501.00
86.00
17.17%
Operating Expenses
134.00
163.00
-29.00
-17.79%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
159.00
31.00
128.00
412.90%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
68.00
6.00
62.00
1,033.33%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
4,714.00
2,066.00
2,648.00
128.17%
Operating Profit (PBDIT) excl Other Income
1,694.00
175.00
1,519.00
868.00%
Other Income
275.00
242.00
33.00
13.64%
Operating Profit (PBDIT)
1,970.00
418.00
1,552.00
371.29%
Interest
11.00
236.00
-225.00
-95.34%
Profit before Depriciation and Tax
1,958.00
181.00
1,777.00
981.77%
Depreciation
71.00
127.00
-56.00
-44.09%
Profit Before Taxation & Exceptional Items
1,886.00
53.00
1,833.00
3,458.49%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1,886.00
660.00
1,226.00
185.76%
Provision for Tax
472.00
51.00
421.00
825.49%
Profit After Tax
1,414.00
609.00
805.00
132.18%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
2,819.00
9,920.00
-7,101.00
-71.58%
Profit Available for appropriations
4,233.00
10,529.00
-6,296.00
-59.80%
Appropriations
4,233.00
10,529.00
-6,296.00
-59.80%
Equity Dividend (%)
4750%
10%
4,740.00
Earnings Per Share
665.62
5.09
660.53
12,977.01%
Profit And Loss - Net Sales
Net Sales 6,409.15 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 9.58% vs 9.35% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,694.60 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 16.62% vs 20.53% in Mar 2024

Profit And Loss - Interest
Interest 11.43 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -8.19% vs -22.14% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 1,414.44 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 17.75% vs 26.52% in Mar 2024